Ovid Therapeutics Inc. (OVID)
NASDAQ: OVID · Real-Time Price · USD
2.700
+0.010 (0.37%)
At close: Apr 28, 2026, 4:00 PM EDT
2.750
+0.050 (1.85%)
After-hours: Apr 28, 2026, 7:55 PM EDT
Ovid Therapeutics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Revenue | 7.25 | 0.57 | 0.39 | 1.5 | 208.38 | Upgrade
|
| Revenue Growth (YoY) | 1181.27% | 44.39% | -73.91% | -99.28% | 1551.57% | Upgrade
|
| Gross Profit | 7.25 | 0.57 | 0.39 | 1.5 | 208.38 | Upgrade
|
| Selling, General & Admin | 24.11 | 23.88 | 29.59 | 32.43 | 37.23 | Upgrade
|
| Research & Development | 25.58 | 35.07 | 28.39 | 24.62 | 46.94 | Upgrade
|
| Operating Expenses | 49.69 | 58.95 | 57.97 | 57.05 | 84.17 | Upgrade
|
| Operating Income | -42.44 | -58.39 | -57.58 | -55.55 | 124.21 | Upgrade
|
| Interest & Investment Income | 2.03 | 3.92 | - | - | - | Upgrade
|
| Other Non Operating Income (Expenses) | 0.15 | 30 | 4.94 | 1.83 | -0.05 | Upgrade
|
| EBT Excluding Unusual Items | -40.27 | -24.47 | -52.64 | -53.71 | 124.16 | Upgrade
|
| Merger & Restructuring Charges | - | -3.5 | -1.7 | - | - | Upgrade
|
| Gain (Loss) on Sale of Investments | 21.05 | 3.34 | 2 | -0.45 | - | Upgrade
|
| Other Unusual Items | 1.8 | -1.8 | - | - | - | Upgrade
|
| Pretax Income | -17.41 | -26.43 | -52.34 | -54.17 | 124.16 | Upgrade
|
| Income Tax Expense | - | - | - | - | 1.33 | Upgrade
|
| Net Income | -17.41 | -26.43 | -52.34 | -54.17 | 122.83 | Upgrade
|
| Preferred Dividends & Other Adjustments | -0.27 | -0.46 | -0.91 | - | 3 | Upgrade
|
| Net Income to Common | -17.14 | -25.98 | -51.43 | -54.17 | 119.84 | Upgrade
|
| Shares Outstanding (Basic) | 74 | 71 | 71 | 70 | 67 | Upgrade
|
| Shares Outstanding (Diluted) | 74 | 71 | 71 | 70 | 68 | Upgrade
|
| Shares Change (YoY) | 3.99% | 0.46% | 0.22% | 3.46% | 16.45% | Upgrade
|
| EPS (Basic) | -0.23 | -0.37 | -0.73 | -0.77 | 1.78 | Upgrade
|
| EPS (Diluted) | -0.23 | -0.37 | -0.73 | -0.77 | 1.76 | Upgrade
|
| Free Cash Flow | -38.33 | -56.03 | -45.82 | -56.45 | 118.43 | Upgrade
|
| Free Cash Flow Per Share | -0.52 | -0.79 | -0.65 | -0.80 | 1.74 | Upgrade
|
| Gross Margin | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | Upgrade
|
| Operating Margin | -585.20% | -10315.37% | -14689.03% | -3696.44% | 59.61% | Upgrade
|
| Profit Margin | -236.38% | -4589.22% | -13119.39% | -3604.66% | 57.51% | Upgrade
|
| Free Cash Flow Margin | -528.60% | -9898.76% | -11689.03% | -3756.55% | 56.83% | Upgrade
|
| EBITDA | -42.17 | -57.77 | -57.01 | -55.04 | 124.45 | Upgrade
|
| EBITDA Margin | - | - | - | - | 59.72% | Upgrade
|
| D&A For EBITDA | 0.27 | 0.61 | 0.57 | 0.51 | 0.24 | Upgrade
|
| EBIT | -42.44 | -58.39 | -57.58 | -55.55 | 124.21 | Upgrade
|
| EBIT Margin | - | - | - | - | 59.61% | Upgrade
|
| Effective Tax Rate | - | - | - | - | 1.07% | Upgrade
|
| Revenue as Reported | 7.25 | 0.57 | 0.39 | 1.5 | 208.38 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.